Katalin Frisch

Statistics

Publications

Citations

287

H-Index

Active since

2003

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Karo Pharma (Sweden)

Katalin Frisch is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in gonadal steroid hormones, steroid hormone signaling, and hormone receptors.

Publications per year

2003–2006

Publications

Estrogen Receptor Ligands. II. Discovery of Benzoxathiins as Potent, Selective Estrogen Receptor α Modulators

Seongkon Kim, Jane Y. Wu, Elizabeth T. Birzin et al. · Journal of Medicinal Chemistry · 2004 · 101 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Estrogen receptor ligands. Part 1: The discovery of flavanoids with subtype selectivity

Helen Y. Chen, Kevin D. Dykstra, Elizabeth T. Birzin et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 52 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +13

The discovery of tetrahydrofluorenones as a new class of estrogen receptor β-subtype selective ligands

Robert R. Wilkening, Ronald W. Ratcliffe, E.C. Tynebor et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 43 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +13

2-Phenylspiroindenes: a novel class of selective estrogen receptor modulators (SERMs)

Timothy A. Blizzard, Jerry D. Morgan, Ralph T. Mosley et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 36 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +13

Estrogen receptor β-subtype selective tetrahydrofluorenones: Use of a fused pyrazole as a phenol bioisostere

Robert R. Wilkening, Ronald W. Ratcliffe, Amy K. Fried et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 34 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16

1–5 of 6